Bioactive Small Molecules

N-(5-methyl-3-isoxazolyl)-4-[methyl(phenylsulfonyl)amino]benzamide

Compound 13

Compound 13 (click to show)
Compound 13 (click to hide)
Title:
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Reference:
PNAS 2007 Aug 7;104(32):13192-7. Epub 2007 Aug 1.
Authors:
Zheng W, Padia J, Urban DJ, Jadhav A, Goker-Alpan O, Simeonov A, Goldin E, Auld D, LaMarca ME, Inglese J, Austin CP, Sidransky E.
Compounds:
Compound 2 (7818198), Compound 10 (7889323), Compound 11 (7935596), Compound 12 (7475785), Compound 13 (7480417), Compound 23 (6432344), Compound 24 (7476484), Compound 25 (6154272), Compound 26 (7916827)